Epana Bio
Epana Bio develops personalized therapies that correct the underlying cellular causes of autoimmune diseases to improve patient outcomes. The company combines patient genomics with AI-driven systems immunology to identify individual immune dysfunctions and design bespoke biologics tailored to each immune profile. Its platform integrates genomic analysis, computational immunology, and biologic engineering to generate precision therapeutic candidates. Epana Bio operates as a B2B biotech working with clinical partners and research institutions to advance candidates toward clinical development.
Epana Bio
Epana Bio develops personalized therapies that correct the underlying cellular causes of autoimmune diseases to improve patient outcomes. The company combines patient genomics with AI-driven systems immunology to identify individual immune dysfunctions and design bespoke biologics tailored to each immune profile. Its platform integrates genomic analysis, computational immunology, and biologic engineering to generate precision therapeutic candidates. Epana Bio operates as a B2B biotech working with clinical partners and research institutions to advance candidates toward clinical development.